QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended ...

Shares of Qiagen (NYSE:QGEN – Get Free Report) have been given an average rating of “Hold” by the ten research firms that are currently covering the company, Marketbeat reports. Seven analysts have ...

Qiagen (NYSE:QGEN) has had a rough three months with its share price down 14%. It seems that the market might have completely ignored the positive aspects of the company's fundamentals and decided to ...

QIAGEN N.V.’s QGEN long-term business strategy focuses on forming partnerships for the development, commercialization, marketing and distribution of existing and future products. The company ...

Jefferies analyst Tycho Peterson maintained a Buy rating on Qiagen (QGEN – Research Report) today. The company’s shares closed yesterday at ...

A month has gone by since the last earnings report for Qiagen (QGEN). Shares have lost about 6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...

Learn more about whether Qiagen N.V. or Stevanato Group S.p.A. is a better investment based on AAII's A+ Investor grades, ...

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and ...

Qiagen (NYSE:QGEN – Free Report) – Equities researchers at Zacks Research decreased their Q4 2025 earnings per share estimates for Qiagen in a note issued to investors on Wednesday, February 26th.

VENLO, The Netherlands & REDWOOD CITY, Calif.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the official opening of a new data center in Melbourne, Australia ...

QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...